Loading…
The company filed a Form S-1 for the offering.
Palisade Bio, Inc. (Nasdaq: PALI) announced the pricing of an underwritten public offering of its common stock on October 01, 2025. The company offered 171,440,559 shares at $0.70 per share, raising a total of $120 million. The offering was filed under Form S-1 (File No. 333-290568).
Additionally, the underwriters have the option to purchase up to 25,714,285 additional shares, as per a Form S-1 filed pursuant to Rule 462(b).
As of the latest data, Palisade Bio has a free float of 102,195,000 shares and 149,003,000 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.